Features of use of measles vaccine

The measles infection is not always preceded by close contact with the patient, the disease agent spreads rapidly for long distances with the air flow in a vehicle, a ventilation shaft, a stairwell. It is the high contagiousness of the disease is the reason that most people tolerate measles in childhood, gaining lifelong immunity.

The fatal cases of measles in children in are now annually taking the lives of 900 children. Symptoms are determined by specific virus which can only replicate in certain cells of the body, the severity of the infectious process depends, in turn, the number of damaged cells. Very often the pathogen infects the cells of the respiratory tract, intestines, CNS.

Among the unvaccinated population measles often affects children aged one year to five years. Children first year of life rarely get sick because of their passive immunity and have a limited social circle.

The most effective way of providing protection for the child against measles, to date is the vaccination.

Measles vaccination is the most effective measure of prevention of the disease

The most important place in preventing measles is active immunisation, which involves the introduction into the organism alive, but severely weakened pathogens that do not pose a danger to humans. The immune system, which appeared after vaccination, is sufficient to protect the child from illness, although it is not as strong as the one formed after the disease.

In contact with the sick person of a child older than 6 months it is possible to put an inoculation from measles within two to three days to protect him from the disease. For children under 6 months of age, and for children who cannot live measles vaccine for prevention can be recommended the normal human immunoglobulin (passive immunization). After three months you can spend and active immunization.

Vaccination against measles: vaccination

Vaccination is carried out twice: at 12-15 months and 6 years. Re-vaccination provides protection to children not previously vaccinated, and those who had formed strong enough immunity after the first vaccination formulation.

Usually the timing of measles vaccine and timing of vaccination against rubella and mumps are the same, however, the possibility of side effects while not increasing.

OnRussia uses domestic single or (Rouvax), Depakine measles and mumps combined vaccine purchased in the US and the UK (MMR II, Priorix).

Differences in the composition of the different vaccines do not affect their ability of formation of immunity and does not affect their transferability. Imported drugs prepared on chicken embryos and is contraindicated with severe allergic reactions to egg white, which is very rare. Domestic products are prepared on the embryos of Japanese quails. Form imported medicines is also considered the most convenient because it provides protection from the three infectious diseases: measles, rubella and mumps. In addition, combine three components in one product reduces the amount of ballast substances, to reduce the number of injections and visits to the hospital.

Measles vaccination of domestic production is placed subcutaneously under the shoulder blade or shoulder area, imported products are introduced as subcutaneously, and intramuscularly.

Measles vaccination: contraindications

Contraindicated to vaccination against measles with the appearance of a severe allergic reaction during a previous vaccination, the presence of Allergy to aminoglycosides, the eggs of birds. The timing of vaccination are carried at exacerbation of chronic diseases and acute course of any disease. In certain cases, such as the child's contact with a person sick with measles, the vaccine may be recommended and if the baby respiratory infections, if it occurs in mild form, and the body temperature does not exceed subfebrile values.

Measles vaccination is contraindicated in the primary or secondary immune deficiency after illness, accompanied by severe immunosuppression, or when taking medications that suppress the immune system.

Not vaccinated children suffering from certain cancers, as well as children who are transfused blood products 8 weeks prior to vaccination.